XETRA · Healthcare
Invest in Redcare Pharmacy stock from India
Indian and foreign residents can buy Redcare Pharmacy (RDC) shares directly through Paasa.
By Paasa · Updated
Redcare Pharmacy at a glance
- Price
- €75.30+€4.20 (5.91%)
- Market cap
- €1.52B
- Day range
- €71.85 – €75.40
- P/E
- -36.03
- Dividend yield
- None
- Volume
- 97.24K
- 1 month
- +18.58%
- 6 months
- +144.01%
- YTD
- +15.67%
- 1 year
- +2.94%
- 5 years
- -41.03%
Redcare Pharmacy statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €2.9B | €2.4B | €1.8B | €1.2B | €1.1B |
| Gross profit | €593.7M | €545.8M | €440.4M | €331.8M | €266.5M |
| Operating income | −€23.8M | −€39.0M | −€17.3M | −€69.2M | −€65.7M |
| Net income | −€37.7M | −€45.5M | −€12.0M | −€77.6M | −€74.2M |
| Earnings per share | −€1.87 | −€2.27 | −€0.63 | −€4.32 | −€4.15 |
| EBITDA | €45.6M | €28.0M | €50.9M | −€30.6M | −€37.4M |
| Total assets | €1.2B | €1.0B | €1.0B | €729.5M | €783.1M |
| Total debt | €415.6M | €247.4M | €244.8M | €255.2M | €236.4M |
| Cash and short-term investments | €203.5M | €177.6M | €204.2M | €184.0M | €283.5M |
| Shareholders' equity | €459.2M | €484.0M | €522.2M | €354.6M | €415.4M |
| Operating cash flow | €23.0M | €22.1M | €61.5M | −€29.1M | €11.6M |
| Free cash flow | −€56.3M | €13.4M | €23.2M | −€82.6M | −€31.5M |
| Capital expenditure | −€79.3M | −€8.7M | −€38.2M | −€53.5M | −€43.2M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Drägerwerk AG & Co. KGaA | DRW3.DE | €120.00 | €2.25B |
| Dermapharm | DMP.DE | €39.35 | €1.95B |
| Drägerwerk AG & Co. KGaA | DRW8.DE | €90.80 | €1.70B |
| Novavax | NVV1.F | €9.51 | €1.56B |
| Bonesupport Holding AB (publ) | 2B4.F | €20.52 | €1.34B |
| Nexus | NXU.DE | €71.20 | €1.23B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 1 buy · 0 hold · 0 sell. Consensus: Buy.
Published sell-side 12-month targets in EUR, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Redcare Pharmacy from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search RDC and buy
Find Redcare Pharmacy by name or by its ticker, RDC, and place your order.
Why invest in Redcare Pharmacy from India
What Redcare Pharmacy does
Redcare Pharmacy N.V. manages and runs a network of digital pharmacies across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a comprehensive selection of healthcare products, including prescription medications, over-the-counter drugs, pharmacy-related beauty and personal care items, and nutritional supplements. Redcare Pharmacy operates in the Medical - Distribution industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Redcare Pharmacy stock from India?
Yes. Indian residents and NRIs can buy Redcare Pharmacy (RDC) shares directly through Paasa. Redcare Pharmacy is listed on XETRA, in the Medical - Distribution industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Redcare Pharmacy dividends taxed for Indian investors?
Redcare Pharmacy trades on XETRA but is domiciled in Netherlands, so any withholding on its dividends follows that country's rules rather than those of Germany. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Redcare Pharmacy shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.